<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyMeetingSummaryOutput xmlns:ns2="local" id="2080524" title="Additional courses of alemtuzumab improved clinical and MRI outcomes in pooled CARE-MS I and II patients with disease activity after three courses: analysis of patients who received &gt;=4 courses"><ConferenceName>34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis</ConferenceName><StartDate>2018-10-10T00:00:00Z</StartDate><EndDate>2018-10-12T00:00:00Z</EndDate><City>Berlin</City><Country>Germany</Country></ns2:com.thomsonreuters.ls.service.contract.soap.ontology.v1.OntologyMeetingSummaryOutput>